Sanofi returns to Dren Bio for another B cell depletion therapy at $100M upfrontnews2025-12-15T14:51:09+00:00December 15th, 2025|Endpoints News|
AI biotech Chai Discovery raises $130M Series B at $1.3B valuationnews2025-12-15T12:30:37+00:00December 15th, 2025|Endpoints News|
Western genetic medicine makers turn to Chinese investigator-initiated trialsnews2025-12-15T12:30:18+00:00December 15th, 2025|Endpoints News|
Sanofi’s multiple sclerosis drug flunks Phase 3 trial, faces another PDUFA delaynews2025-12-15T12:19:41+00:00December 15th, 2025|Endpoints News|
Argenx cans thyroid eye disease trials of Vyvgart Hytrulonews2025-12-15T11:39:08+00:00December 15th, 2025|Endpoints News|
Sobi to buy gout biotech Arthrosi for $950M upfrontnews2025-12-15T08:47:48+00:00December 15th, 2025|Endpoints News|
Milestone finally wins FDA approval for arrythmia nasal spraynews2025-12-15T01:31:55+00:00December 15th, 2025|Endpoints News|
Eli Lilly’s triple-G obesity readout; The latest Endpoints 100 results; Public biotechs cash in; and morenews2025-12-13T11:00:18+00:00December 13th, 2025|Endpoints News|
340B sales grew 23% last year, and court battle over pilot program intensifies news2025-12-12T20:47:51+00:00December 12th, 2025|Endpoints News|
Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources saynews2025-12-12T20:36:22+00:00December 12th, 2025|Endpoints News|
